Tarsus Pharmaceuticals, Inc. (TARS)
72.01
-0.80
(-1.10%)
USD |
NASDAQ |
Aug 25, 13:03
Tarsus Pharmaceuticals Market Cap : 3.116B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.151B |
| August 21, 2026 | 3.146B |
| August 20, 2026 | 3.093B |
| August 19, 2026 | 3.178B |
| August 18, 2026 | 3.074B |
| August 17, 2026 | 3.056B |
| August 14, 2026 | 2.994B |
| August 13, 2026 | 2.981B |
| August 12, 2026 | 3.030B |
| August 11, 2026 | 3.006B |
| August 10, 2026 | 2.932B |
| August 07, 2026 | 2.804B |
| August 06, 2026 | 2.827B |
| August 05, 2026 | 2.652B |
| August 04, 2026 | 2.644B |
| August 03, 2026 | 2.638B |
| July 31, 2026 | 2.540B |
| July 30, 2026 | 2.561B |
| July 29, 2026 | 2.518B |
| July 28, 2026 | 2.536B |
| July 27, 2026 | 2.586B |
| July 24, 2026 | 2.524B |
| July 23, 2026 | 2.520B |
| July 22, 2026 | 2.477B |
| July 21, 2026 | 2.463B |
| Date | Value |
|---|---|
| July 20, 2026 | 2.420B |
| July 17, 2026 | 2.575B |
| July 16, 2026 | 2.482B |
| July 15, 2026 | 2.474B |
| July 14, 2026 | 2.414B |
| July 13, 2026 | 2.552B |
| July 10, 2026 | 2.501B |
| July 09, 2026 | 2.759B |
| July 08, 2026 | 2.914B |
| July 07, 2026 | 3.035B |
| July 06, 2026 | 2.885B |
| July 02, 2026 | 2.815B |
| July 01, 2026 | 2.620B |
| June 30, 2026 | 2.708B |
| June 29, 2026 | 2.635B |
| June 26, 2026 | 2.707B |
| June 25, 2026 | 2.768B |
| June 24, 2026 | 2.887B |
| June 23, 2026 | 2.847B |
| June 22, 2026 | 2.734B |
| June 18, 2026 | 2.717B |
| June 17, 2026 | 2.691B |
| June 16, 2026 | 2.616B |
| June 15, 2026 | 2.661B |
| June 12, 2026 | 2.665B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Structure Therapeutics, Inc. | 3.547B |
| Alumis, Inc. | 2.999B |
| Veradermics, Inc. | 4.320B |
| ANI Pharmaceuticals, Inc. | 1.707B |
| Corcept Therapeutics, Inc. | 13.26B |
Market Cap Related Metrics
| PS Ratio | 5.099 |
| Price to Book Value | 8.987 |
| Price to Free Cash Flow | 55.21 |
| Price | 72.01 |
| Earnings Yield | -1.50% |